Investors & News / Media Coverage / Media Coverage Year None202420222020201920172016 Apr 09, 2019 Regulating Regeneration in Europe Apr 03, 2019 Caladrius Biosciences selected as BioNJ’s Emerging Company in the Spotlight Mar 08, 2019 FutureTech Podcast featuring Douglas W. Losordo, MD, FACC, FAHA, Executive Vice President, Global Head of Research and Development, Caladrius Biosciences – Cells, Tissue, and Repair Aug 08, 2017 Cell Therapy Trial Targets Type 1 Diabetes In Children Jul 20, 2017 Type 1 Diabetes Cell Therapy Study Shows Promise in Pediatrics Apr 13, 2017 Practical Cure Project Update: Caladrius Biosciences Inc. Treg Apr 07, 2017 Close Concerns Highlights Caladrius Type 1 Diabetes Program and Recent CIRM Grant Nov 14, 2016 CEOCFO Magazine Interview with Dr. David Mazzo Oct 19, 2016 Stock News Now Interview with Dr. David Mazzo Sep 14, 2016 A first for Fast Track designation First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last » Print Page RSS Feeds Email Alerts
Year None202420222020201920172016 Apr 09, 2019 Regulating Regeneration in Europe Apr 03, 2019 Caladrius Biosciences selected as BioNJ’s Emerging Company in the Spotlight Mar 08, 2019 FutureTech Podcast featuring Douglas W. Losordo, MD, FACC, FAHA, Executive Vice President, Global Head of Research and Development, Caladrius Biosciences – Cells, Tissue, and Repair Aug 08, 2017 Cell Therapy Trial Targets Type 1 Diabetes In Children Jul 20, 2017 Type 1 Diabetes Cell Therapy Study Shows Promise in Pediatrics Apr 13, 2017 Practical Cure Project Update: Caladrius Biosciences Inc. Treg Apr 07, 2017 Close Concerns Highlights Caladrius Type 1 Diabetes Program and Recent CIRM Grant Nov 14, 2016 CEOCFO Magazine Interview with Dr. David Mazzo Oct 19, 2016 Stock News Now Interview with Dr. David Mazzo Sep 14, 2016 A first for Fast Track designation First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last »
Mar 08, 2019 FutureTech Podcast featuring Douglas W. Losordo, MD, FACC, FAHA, Executive Vice President, Global Head of Research and Development, Caladrius Biosciences – Cells, Tissue, and Repair